Search results for " Igiene"

showing 10 items of 754 documents

Risk of classic Kaposi sarcoma with exposures to plants and soils in Sicily

2010

Abstract Background Ecologic and in vitro studies suggest that exposures to plants or soil may influence risk of Kaposi sarcoma (KS). Methods In a population-based study of Sicily, we analyzed data on contact with 20 plants and residential exposure to 17 soils reported by 122 classic KS cases and 840 sex- and age-matched controls. With 88 KS-associated herpesvirus (KSHV) seropositive controls as the referent group, novel correlates of KS risk were sought, along with factors distinguishing seronegatives, in multinomial logistic regression models that included matching variables and known KS cofactors - smoking, cortisone use, and diabetes history. All plants were summed for cumulative exposu…

Cancer ResearchPathologymedicine.medical_specialtyClassic Kaposi Sarcomabusiness.industryEpidemiologyvirus diseasesfood and beveragesPhysiologymedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensSettore MED/42 - Igiene Generale E Applicatalcsh:RC254-282lcsh:Infectious and parasitic diseasesInfectious DiseasesOncologySoil watermedicinelcsh:RC109-216SarcomabusinessHERPESVIRIDAE KAPOSI SARCOMA ITALY ECOLOGY PLANTS NATURAL PRODUCTS SOILSResearch ArticleInfectious Agents and Cancer
researchProduct

Optimal duration of low molecular weight heparin for the treatment of cancer-related deep vein thrombosis. The ”CANCER DACUS” study

2014

Purpose We evaluated the role of residual vein thrombosis (RVT) to assess the optimal duration of anticoagulants in patients with cancer who have deep vein thrombosis (DVT) of the lower limbs. Patients and Methods Patients with active cancer and a first episode of DVT treated with low molecular weight heparin (LMWH) for 6 months were eligible. Patients were managed according to RVT findings: those with RVT were randomly assigned to continue LMWH for an additional 6 months (group A1) or to discontinue it (group A2), and patients without RVT stopped LMWH (group B). The primary end point was recurrent venous thromboembolism (VTE) during the 1 year after disconinuation of LMWH, and the secondar…

Cancer Researchmedicine.medical_specialtymedicine.drug_classDeep veinPopulationLow molecular weight heparinSettore MED/42 - Igiene Generale E ApplicataGroup BSettore MED/15 - Malattie Del SangueInternal medicineresidual vein thrombosis low molecular weight heparin cancer patientsmedicineeducationFirst episodeeducation.field_of_studybusiness.industrylow molecular weight heparinHazard ratioantivitamin K; low molecular weight heparin; nadroparinCancermedicine.diseaseThrombosisSurgerymedicine.anatomical_structureOncologynadroparinantivitamin Kbusiness
researchProduct

Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and match…

2011

Kaposi sarcoma (KS) might develop because of incompetent immune responses, both non-specifically and specifically against the KS-associated herpesvirus (KSHV). Peripheral blood mononuclear cells from 15 classic (non-AIDS) KS cases, 13 KSHV seropositives (without KS) and 15 KSHV-seronegative controls were tested for interferon-γ T-cell (enzyme-linked immunospot [Elispot]) responses to KSHV-latency-associated nuclear antigen (LANA), KSHV-K8.1 and CMV/Epstein-Barr virus (EBV) peptide pools. The forearm and thigh of each participant was also tested for delayed-type hypersensitivity (DTH) against common recall antigens. Groups were compared with Fisher exact test and multinomial logistic regress…

Cancer ResearchvirusesT-LymphocytesEnzyme-Linked Immunosorbent AssayBiologyAntibodies ViralSettore MED/42 - Igiene Generale E ApplicataPeripheral blood mononuclear cellArticleInterferon-gammaViral ProteinsImmune systemAntigenInterferonmedicineHumansInterferon gammaHypersensitivity DelayedAntigens ViralSarcoma KaposiSicilyGlycoproteinsKSHV SicilyClassic Kaposi SarcomaELISPOTvirus diseasesNuclear ProteinsAntigens NuclearGeneral Medicinebiochemical phenomena metabolism and nutritionmedicine.diseaseVirologyImmunity InnateKaposi sarcoma; HHV8; ELISPOT; immune responseOncologyCase-Control StudiesImmunologyHerpesvirus 8 HumanLeukocytes MononuclearSarcomamedicine.drug
researchProduct

Posaconazole against Candida glabrata with Variable Susceptibility to Fluconazole

2008

We investigated the in vitro activities of posaconazole (POS), fluconazole (FLC), amphotericin B (AMB), and caspofungin (CAS) against four clinical isolates of Candida glabrata with various susceptibilities to FLC (FLC MICs ranging from 1.0 to >64 microg/ml). POS MICs ranged from 64 microg/ml; POS MIC of 0.5 microg/ml). FLC significantly reduced the kidney burden of mice infected with the S strain (P = 0.0070) but not of those infected with the S-DD and R strains. POS was significantly effective against all three isolates at reducing the kidney fungal burden with respect to the controls (P ranging from 0.0003 to 0.029). In conclusion, our data suggest that POS may be a useful option in the …

Candida glabrata posaconazole azoles MICSettore MED/42 - Igiene Generale E Applicata
researchProduct

The burden of Candida species colonization in NICU patients: a colonization surveillance study

2017

Fungal infections are an important cause of morbidity and mortality in neonatal intensive care units (NICUs). The identifi-cation of specific risk factors supports pre-vention of candidemia in neonates. Effec-tive prophylactic strategies have recently become available, but the identification and adequate management of high-risk in-fants is still a priority. Prior colonization is a key risk factor for candidemia. For this reason, surveillance studies to monitor in-cidence, species distribution, and antifun-gal susceptibility profiles, are mandatory. Among 520 infants admitted to our NICU between January 2013 and December 2014, 472 (90.77%) were included in the study. Forty-eight out of 472 (…

Candida; surveillance; NICUmedicine.medical_specialtySurveillance studymedicine.medical_treatment02 engineering and technology010402 general chemistryCritical Care and Intensive Care MedicineSettore MED/42 - Igiene Generale E Applicata01 natural sciencesInternal medicineIntensive caremedicineColonizationRisk factorbusiness.industry021001 nanoscience & nanotechnology0104 chemical sciencesParenteral nutritionCandida surveillance NICUNasal SwabEmergency MedicineCandida spp0210 nano-technologybusinessCentral venous catheter
researchProduct

Valutazione di un modello applicativo per lo screening del carcinoma colon-rettale nella Provincia di Palermo.

2010

Carcinoma Colon-rettale Screening Prevenzione SecondariaSettore MED/42 - Igiene Generale E Applicata
researchProduct

The Carini experimental station for wastewater reuse in agricolture.

1992

Cariniexperimental station wastewater reuseSettore MED/42 - Igiene Generale E Applicata
researchProduct

Appropriatezza dell'uso degli antibiotici e contenimento dell'antibioticoresistenza. Indagine nell'Azienda Ospedaliera Universitaria Policlinico (A.O…

2010

Cartelle cliniche antibiotici.Settore MED/42 - Igiene Generale E Applicata
researchProduct

L’aderenza ai programmi vaccinali per la prima infanzia nella popolazione di origine straniera regolarmente residente. L’esperienza di quattro centri…

2013

Centri Vaccinali popolazione Migrante adesione vaccinaleSettore MED/42 - Igiene Generale E Applicata
researchProduct

La gestione del paziente grande obeso: l'esperienza dell'Azienda Ospedaliera Universitaria Policlinico (A.O.U.P.) "P. Giaccone" di Palermo

2011

Chirurgia bariatrica grande obesoSettore MED/42 - Igiene Generale E Applicata
researchProduct